The treatment of meningitis depends on the causative agent. Bacterial meningitis requires immediate administration of antibiotics, often intravenously, to target the specific bacteria involved. Viral meningitis is generally self-limiting, and supportive care, including pain management and hydration, is the mainstay of treatment. Antiviral medications may be considered for specific viral etiologies. Complications of meningitis can be severe and may include neurological deficits, hearing loss, and, in some cases, long-term cognitive impairment. In Bacterial Meningitis, complications can arise rapidly, emphasizing the importance of timely intervention. Preventive measures for meningitis include vaccination, especially for bacterial causes. Routine childhood immunizations often include vaccines against Haemophilus influenzae type b, Neisseria meningitidis, and Streptococcus pneumoniae. Meningococcal vaccines are crucial for individuals at increased risk of meningococcal disease. Outbreaks of meningitis, particularly in crowded settings like college campuses or military barracks, may prompt mass vaccination campaigns to curb the spread of the disease. Public health efforts also focus on early detection, contact tracing, and prophylactic antibiotic treatment for close contacts of individuals with certain types of Bacterial Meningitis. While significant progress has been made in preventing and treating meningitis, challenges such as emerging Antibiotic Resistance and the need for improved vaccines persist. Ongoing research aims to enhance our understanding of the pathogenesis of meningitis, develop new treatment modalities, and optimize preventive strategies to reduce the global burden of this potentially life-threatening infection.